Nanoview Biosciences Company
nanoView Diagnostics Inc. (dba NanoView Biosciences), is developing proprietary products that support research, translation and delivery of precision medicine. The Company was founded on a novel technology platform that uniquely identifies and characterizes exosomes. Our high-throughput, cost-effective analysis solutions enable life science researchers to better understand the biological role of exosomes and how to utilize them as biomarkers to provide improved insight for how diseases are diagnosed, treated and monitored.
Industry:
P4 Medicine
Technology:
Other
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Investors Number:
5
Headquarters:
Boston, Massachusetts, United States
Employee Number:
11-50
Total Funding:
21850000
Founded Date:
2015-01-01
Last Funding Type:
Series B